GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » 3-Year EBITDA Growth Rate

SOFIVA GENOMICS Co (ROCO:6615) 3-Year EBITDA Growth Rate : -15.30% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co 3-Year EBITDA Growth Rate?

SOFIVA GENOMICS Co's EBITDA per Share for the three months ended in Mar. 2025 was NT$0.29.

During the past 12 months, SOFIVA GENOMICS Co's average EBITDA Per Share Growth Rate was -23.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -15.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -12.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of SOFIVA GENOMICS Co was 13.00% per year. The lowest was -16.10% per year. And the median was -1.15% per year.


Competitive Comparison of SOFIVA GENOMICS Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOFIVA GENOMICS Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where SOFIVA GENOMICS Co's 3-Year EBITDA Growth Rate falls into.


;
;

SOFIVA GENOMICS Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


SOFIVA GENOMICS Co  (ROCO:6615) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


SOFIVA GENOMICS Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of SOFIVA GENOMICS Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


SOFIVA GENOMICS Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66-1, Section 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines